Cargando…

Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy

Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Takahiro, Yano, Naoko, Kora, Kengo, Yokoyama, Atsushi, Maizuru, Kanako, Kayaki, Taisei, Nishikawa, Kinuko, Osawa, Mitsujiro, Niwa, Akira, Takenouchi, Toshiki, Hijikata, Atsushi, Shirai, Tsuyoshi, Suzuki, Hisato, Kosaki, Kenjiro, Saito, Megumu K, Takita, Junko, Yoshida, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162430/
https://www.ncbi.nlm.nih.gov/pubmed/36645181
http://dx.doi.org/10.1093/hmg/ddad008
_version_ 1785037698279407616
author Hayashi, Takahiro
Yano, Naoko
Kora, Kengo
Yokoyama, Atsushi
Maizuru, Kanako
Kayaki, Taisei
Nishikawa, Kinuko
Osawa, Mitsujiro
Niwa, Akira
Takenouchi, Toshiki
Hijikata, Atsushi
Shirai, Tsuyoshi
Suzuki, Hisato
Kosaki, Kenjiro
Saito, Megumu K
Takita, Junko
Yoshida, Takeshi
author_facet Hayashi, Takahiro
Yano, Naoko
Kora, Kengo
Yokoyama, Atsushi
Maizuru, Kanako
Kayaki, Taisei
Nishikawa, Kinuko
Osawa, Mitsujiro
Niwa, Akira
Takenouchi, Toshiki
Hijikata, Atsushi
Shirai, Tsuyoshi
Suzuki, Hisato
Kosaki, Kenjiro
Saito, Megumu K
Takita, Junko
Yoshida, Takeshi
author_sort Hayashi, Takahiro
collection PubMed
description Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive factor (NSF), a homohexameric ATPase, disassembles the complex, allowing individual SNARE proteins to be recycled. Recently, the association between pathogenic NSF variants and developmental and epileptic encephalopathy (DEE) was reported; however, the molecular pathomechanism of NSF-related DEE remains unclear. Here, three patients with de novo heterozygous NSF variants were presented, of which two were associated with DEE and one with a very mild phenotype. One of the DEE patients also had hypocalcemia from parathyroid hormone deficiency and neuromuscular junction impairment. Using PC12 cells, a neurosecretion model, we show that NSF with DEE-associated variants impaired the recycling of vesicular membrane proteins and vesicle enlargement in response to exocytotic stimulation. In addition, DEE-associated variants caused neurodegenerative change and defective autophagy through overactivation of the mammalian/mechanistic target of rapamycin (mTOR) pathway. Treatment with rapamycin, an mTOR inhibitor or overexpression of wild-type NSF ameliorated these phenotypes. Furthermore, neurons differentiated from patient-derived induced pluripotent stem cells showed neurite degeneration, which was also alleviated by rapamycin treatment or gene correction using genome editing. Protein structure analysis of NSF revealed that DEE-associated variants might disrupt the transmission of the conformational change of NSF monomers and consequently halt the rotation of ATP hydrolysis, indicating a dominant negative mechanism. In conclusion, this study elucidates the pathomechanism underlying NSF-related DEE and identifies a potential therapeutic approach.
format Online
Article
Text
id pubmed-10162430
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101624302023-05-06 Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy Hayashi, Takahiro Yano, Naoko Kora, Kengo Yokoyama, Atsushi Maizuru, Kanako Kayaki, Taisei Nishikawa, Kinuko Osawa, Mitsujiro Niwa, Akira Takenouchi, Toshiki Hijikata, Atsushi Shirai, Tsuyoshi Suzuki, Hisato Kosaki, Kenjiro Saito, Megumu K Takita, Junko Yoshida, Takeshi Hum Mol Genet Original Article Membrane fusion is mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. During neurotransmitter exocytosis, SNARE proteins on a synaptic vesicle and the target membrane form a complex, resulting in neurotransmitter release. N-ethylmaleimide-sensitive factor (NSF), a homohexameric ATPase, disassembles the complex, allowing individual SNARE proteins to be recycled. Recently, the association between pathogenic NSF variants and developmental and epileptic encephalopathy (DEE) was reported; however, the molecular pathomechanism of NSF-related DEE remains unclear. Here, three patients with de novo heterozygous NSF variants were presented, of which two were associated with DEE and one with a very mild phenotype. One of the DEE patients also had hypocalcemia from parathyroid hormone deficiency and neuromuscular junction impairment. Using PC12 cells, a neurosecretion model, we show that NSF with DEE-associated variants impaired the recycling of vesicular membrane proteins and vesicle enlargement in response to exocytotic stimulation. In addition, DEE-associated variants caused neurodegenerative change and defective autophagy through overactivation of the mammalian/mechanistic target of rapamycin (mTOR) pathway. Treatment with rapamycin, an mTOR inhibitor or overexpression of wild-type NSF ameliorated these phenotypes. Furthermore, neurons differentiated from patient-derived induced pluripotent stem cells showed neurite degeneration, which was also alleviated by rapamycin treatment or gene correction using genome editing. Protein structure analysis of NSF revealed that DEE-associated variants might disrupt the transmission of the conformational change of NSF monomers and consequently halt the rotation of ATP hydrolysis, indicating a dominant negative mechanism. In conclusion, this study elucidates the pathomechanism underlying NSF-related DEE and identifies a potential therapeutic approach. Oxford University Press 2023-01-16 /pmc/articles/PMC10162430/ /pubmed/36645181 http://dx.doi.org/10.1093/hmg/ddad008 Text en © The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hayashi, Takahiro
Yano, Naoko
Kora, Kengo
Yokoyama, Atsushi
Maizuru, Kanako
Kayaki, Taisei
Nishikawa, Kinuko
Osawa, Mitsujiro
Niwa, Akira
Takenouchi, Toshiki
Hijikata, Atsushi
Shirai, Tsuyoshi
Suzuki, Hisato
Kosaki, Kenjiro
Saito, Megumu K
Takita, Junko
Yoshida, Takeshi
Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
title Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
title_full Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
title_fullStr Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
title_full_unstemmed Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
title_short Involvement of mTOR pathway in neurodegeneration in NSF-related developmental and epileptic encephalopathy
title_sort involvement of mtor pathway in neurodegeneration in nsf-related developmental and epileptic encephalopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162430/
https://www.ncbi.nlm.nih.gov/pubmed/36645181
http://dx.doi.org/10.1093/hmg/ddad008
work_keys_str_mv AT hayashitakahiro involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT yanonaoko involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT korakengo involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT yokoyamaatsushi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT maizurukanako involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT kayakitaisei involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT nishikawakinuko involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT osawamitsujiro involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT niwaakira involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT takenouchitoshiki involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT hijikataatsushi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT shiraitsuyoshi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT suzukihisato involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT kosakikenjiro involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT saitomegumuk involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT takitajunko involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy
AT yoshidatakeshi involvementofmtorpathwayinneurodegenerationinnsfrelateddevelopmentalandepilepticencephalopathy